(Q40405369)

20 September 2017

1 reference

title

Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy (English)

1 reference

20 September 2017

1 reference

2

Blomqvist C

1 reference

20 September 2017

Elomaa I

1

1 reference

20 September 2017

1 January 1995

1 reference

20 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Acta Oncologica

1 reference

20 September 2017

34

1 reference

20 September 2017

629-636

1 reference

20 September 2017

5

1 reference

Osteoclasts and the resorption of bone by transplanted mammary carcinoma in rats

20 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Tumor products and the hypercalcemia of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Spread of prostatic cancer to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Absorption of oral diphosphonate in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Severe hypocalcaemia [corrected] after treatment with diphosphonate and aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Treatment of malignant hypercalcaemia with clodronate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Controlled Clinical Study on the Use of Dichloromethylene Diphosphonate in Patients with Breast Carcinoma Metastasizing to the Skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

Direct resorption of bone by human breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869509094039

10.3109/02841869509094039

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7546830